New research out of Toronto, Canada, suggests precision magnetics could be a game-changer for therapy-resistant brain cancers
Scientists at The Hospital for Sick Children (SickKids) and the University of Toronto (U of T) have combined forces to develop a new therapy approach to potentially treat tumour cells, called mechanical nanosurgery, even for aggressive, chemoresistant cancers.
Glioblastoma (GBM) is the most common and aggressive primary brain cancer.
Despite various treatment options that exist, including surgery, radiotherapy, and chemotherapy, the median survival time for patients is only around 15 months.
The current global standard-of-care treatment for GBM patients includes chemotherapy using a drug called temozolomide (TMZ), which extends a person’s life expectancy by approximately two months compared to patients receiving radiotherapy alone.
However, GBM cells can develop resistance to TMZ over time, reducing its efficacy and increasing the likelihood of tumour relapse.
In a new study, Dr Xi Huang, a senior scientist in the Developmental & Stem Cell Biology program at SickKids, and Dr Yu Sun, Professor of Mechanical Engineering and Director of the Robotics Institute at U of T, present a new approach to treating chemoresistant GBM using precision magnetic control in a process they call mechanical nanosurgery.
Huang, whose previous research demonstrating that brain tumour cells are mechanosensitive helped to inform the approach, said: “Through the use of nanotechnology deep inside cancer cells, mechanical nanosurgery is a ‘Trojan Horse’ approach that could allow us to destroy tumour cells from within.
“By combining our expertise in biochemistry at SickKids and engineering at U of T, we’ve developed a potential new way to treat aggressive brain cancer.”
Developed with first author Dr Xian Wang, current Assistant Professor at Queen’s University, former post-doctoral fellow in the Huang Lab and winner of a Lap-Chee Tsui Fellowship through the SickKids Research Training Centre, the mouse model used in the study showed that the mechanical nanosurgery process reduced GBM tumour size universally, including in TMZ-resistant GBM.
- Children born from frozen embryos have ‘higher risk of cancer’ study finds
- Breakthrough in cancer biopsy identification
- Heat-efficient nanoparticles for treating cancer developed
How it works
Magnetic carbon nanotubes (mCNTs) are a form of nanomaterial – microscopic cylindrically-shaped tubes made of carbon and, in this case, filled with iron that becomes magnetised when activated by an external magnetic field.
In the study, the research team coated mCNTs with an antibody that recognises a specific protein associated with GBM tumour cells.
Once injected into the tumour, the antibodies on the mCNTs cause them to seek out tumour cells and are absorbed by them.
Sun said: “Once the nanotubes are inside the tumour cell, we use a rotating magnetic field to mechanically mobilise the nanotubes to provide mechanical stimulation.
“The force exerted by the nanotubes damages cellular structures and cause tumour cell death.”
Other cancers
Huang’s partnership with Sun at the U of T Department of Mechanical Engineering is continuing to build on the study findings.
As their research continues, they note that mechanical nanosurgery may have further applications in developing therapies for other cancer types.
Huang said: “Theoretically, by changing the antibody coating and redirecting nanotubes to the desired tumour site, we could potentially have a means to precisely destroy tumour cells in other cancers.”
The research is published in Science Advances
Image: Artistic rendering illustrating how the mechanical nanosurgery, a new approach developed by SickKids and University of Toronto researchers, targets cancer cells from inside the tumour, sparing healthy tissue in the process. © Created by The Hospital for Sick Children (SickKids) research team using Midjourney (CC BY-NC) https://creativecommons.org/licenses/by-nc/4.0/legalcode
